tovorafenib,day101
day one biopharmaceutical
['tovorafenib', 'firefly-1', '$dawn']
jp $dawn win scenario hit at asco with tovorafenib firefly-1 results -expect an increased focus now on regulatory process (rolling nda started/completed in october 2023, which will include a june 2023 cut-off). based on totality of data&amp;unmet need, expecting a smooth process 
BIOTECH man LONGTERM FOCUS many positions-also trade around my CORE holdings my opinion only do your own research with me